AMGEN INC - AMGN

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$174.1B

QoQ value delta ($000)

+$27.71B (+18.93%)

Implied price effect (QoQ)

+6.5%

Total shares

499,553,464

QoQ shares delta

+52,197,586 (+11.67%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 3096 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
VANGUARD GROUP INC	17,949,296	54,838,826	0.26%
BlackRock, Inc.	16,572,301	47,100,472	0.29%
VANGUARD CAPITAL MANAGEMENT LLC	12,319,757	35,014,232	0.31%
STATE STREET CORP	10,748,485	30,548,488	0.37%
Capital World Investors	10,304,790	29,288,343	1.41%
MORGAN STANLEY	5,571,918	15,836,058	0.34%
GEODE CAPITAL MANAGEMENT, LLC	5,412,923	15,430,524	0.34%
VANGUARD PORTFOLIO MANAGEMENT LLC	5,144,450	14,621,148	0.27%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	4,494,315	12,773,386	0.69%
PRIMECAP MANAGEMENT CO/CA/	3,122,362	8,874,129	2.46%
JPMORGAN CHASE & CO	2,539,965	7,277,837	0.16%
Capital International Investors	2,505,117	7,122,275	0.59%
WELLS FARGO & COMPANY/MN	2,494,654	7,090,110	0.47%
Capital Research Global Investors	2,447,115	6,955,345	0.38%
NORTHERN TRUST CORP	2,187,746	6,217,838	0.29%
NORGES BANK	2,164,162	6,611,965	0.23%
BANK OF AMERICA CORP /DE/	1,801,833	5,121,028	0.13%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,683,595	4,784,982	0.35%
Invesco Ltd.	1,608,561	4,571,725	0.25%
ROYAL BANK OF CANADA	1,575,284	4,477,145	0.28%
GOLDMAN SACHS GROUP INC	1,554,223	4,417,289	0.18%
Legal & General Group Plc	1,361,963	3,870,863	0.31%
Bank of New York Mellon Corp	1,334,723	3,793,443	0.25%
FMR LLC	1,328,736	3,776,430	0.07%
Amundi	1,188,305	3,377,306	0.32%